Showing results (81-90 of 183) with videos related to
Sort By:
Pageof 19
Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine|September 11, 2024
Evaluation of Sonographic Muscle Measurement Using Established Muscle MarkersWolfgang Maximilian Kremer, Alexander Schwarz, Markus Schepers, et al.Scientific Reports|June 6, 2023
Metabolic dysfunction-associated fatty liver disease in people living with HIVMaurice Michel, Christian Labenz, Angelo Armandi, et al.Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|July 10, 2020
Clinical Frailty Scale for risk stratification in patients with SARS-CoV-2 infectionChristian Labenz, Wolfgang M Kremer, Jörn M Schattenberg, et al.Clinical and Translational Gastroenterology|June 23, 2020
Outcome Prediction of Covert Hepatic Encephalopathy in Liver Cirrhosis: Comparison of Four Testing StrategiesChristian Labenz, Gerrit Toenges, Jörn M Schattenberg, et al.The American Journal of Gastroenterology|March 9, 2019
Development and Validation of a Prognostic Score to Predict Covert Hepatic Encephalopathy in Patients With CirrhosisChristian Labenz, Gerrit Toenges, Yvonne Huber, et al.Journal of Neurochemistry|December 31, 2020
Bile-duct ligation renders the brain susceptible to hypotension-induced neuronal degeneration: Implications of ammoniaMarc-André Clément, Cristina R Bosoi, Mariana M Oliveira, et al.Alimentary Pharmacology & Therapeutics|October 5, 2019
Raised serum Interleukin-6 identifies patients with liver cirrhosis at high risk for overt hepatic encephalopathyChristian Labenz, Gerrit Toenges, Yvonne Huber, et al.Metabolic Brain Disease|June 9, 2016
Brain edema: a valid endpoint for measuring hepatic encephalopathy?Chantal Bémeur, Cristina Cudalbu, Gitte Dam, et al.Zeitschrift Fur Gastroenterologie|January 14, 2020
Management of hepatic encephalopathy in Germany: a survey among physiciansChristian Labenz, Charles C Adarkwah, Marcus-Alexander Wörns, et al.Digestive Diseases (Basel, Switzerland)|July 5, 2017
Impact of Individual Components of the Metabolic Syndrome on the Outcome of Patients with Advanced Hepatocellular Carcinoma Treated with SorafenibChristian Labenz, Vera Prenosil, Sandra Koch, et al.Pageof 19